424 related articles for article (PubMed ID: 9788969)
1. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
Véniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D; Herz J; Young SG
J Clin Invest; 1998 Oct; 102(8):1559-68. PubMed ID: 9788969
[TBL] [Abstract][Full Text] [Related]
2. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
[TBL] [Abstract][Full Text] [Related]
3. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
Linton MF; Hasty AH; Babaev VR; Fazio S
J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
[TBL] [Abstract][Full Text] [Related]
4. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
Wang HH; Wang DQ
Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
Farese RV; Véniant MM; Cham CM; Flynn LM; Pierotti V; Loring JF; Traber M; Ruland S; Stokowski RS; Huszar D; Young SG
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6393-8. PubMed ID: 8692825
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.
Willnow TE; Sheng Z; Ishibashi S; Herz J
Science; 1994 Jun; 264(5164):1471-4. PubMed ID: 7515194
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
Véniant MM; Pierotti V; Newland D; Cham CM; Sanan DA; Walzem RL; Young SG
J Clin Invest; 1997 Jul; 100(1):180-8. PubMed ID: 9202070
[TBL] [Abstract][Full Text] [Related]
8. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
[TBL] [Abstract][Full Text] [Related]
9. A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing "apoB39-only" mice with mouse apoB48.
Nguyen AT; Braschi S; Geoffrion M; Fong LG; Crooke RM; Graham MJ; Young SG; Milne R
Biochim Biophys Acta; 2006 Feb; 1761(2):182-5. PubMed ID: 16551509
[TBL] [Abstract][Full Text] [Related]
10. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol.
Sorci-Thomas M; Wilson MD; Johnson FL; Williams DL; Rudel LL
J Biol Chem; 1989 May; 264(15):9039-45. PubMed ID: 2722816
[TBL] [Abstract][Full Text] [Related]
11. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
[TBL] [Abstract][Full Text] [Related]
12. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
[TBL] [Abstract][Full Text] [Related]
13. Insulin suppression of VLDL apo B secretion is not mediated by the LDL receptor.
Chirieac DV; Cianci J; Collins HL; Sparks JD; Sparks CE
Biochem Biophys Res Commun; 2002 Sep; 297(1):134-7. PubMed ID: 12220520
[TBL] [Abstract][Full Text] [Related]
14. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
[TBL] [Abstract][Full Text] [Related]
15. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.
Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1745-52. PubMed ID: 18617647
[TBL] [Abstract][Full Text] [Related]
16. The role of the LDL receptor in apolipoprotein B secretion.
Twisk J; Gillian-Daniel DL; Tebon A; Wang L; Barrett PH; Attie AD
J Clin Invest; 2000 Feb; 105(4):521-32. PubMed ID: 10683382
[TBL] [Abstract][Full Text] [Related]
17. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.
Herz J; Qiu SQ; Oesterle A; DeSilva HV; Shafi S; Havel RJ
Proc Natl Acad Sci U S A; 1995 May; 92(10):4611-5. PubMed ID: 7753850
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100.
Stefansson S; Chappell DA; Argraves KM; Strickland DK; Argraves WS
J Biol Chem; 1995 Aug; 270(33):19417-21. PubMed ID: 7642623
[TBL] [Abstract][Full Text] [Related]
19. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.
Leppänen P; Koota S; Kholová I; Koponen J; Fieber C; Eriksson U; Alitalo K; Ylä-Herttuala S
Circulation; 2005 Aug; 112(9):1347-52. PubMed ID: 16129816
[TBL] [Abstract][Full Text] [Related]
20. Identification of the proteoglycan binding site in apolipoprotein B48.
Flood C; Gustafsson M; Richardson PE; Harvey SC; Segrest JP; Borén J
J Biol Chem; 2002 Aug; 277(35):32228-33. PubMed ID: 12070165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
